HIRSCHMAN ORIN 13D and 13G filings for CAMP4 Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-21 10:34 am Sale | 2023-12-20 | 13G | CAMP4 Therapeutics Corporation CAMP | HIRSCHMAN ORIN | 0 0.000% | -101,215 (Position Closed) | Filing |
| 2023-02-15 06:16 am Purchase | 2022-12-31 | 13G | CAMP4 Therapeutics Corporation CAMP | HIRSCHMAN ORIN | 101,215 6.400% | 5,563 (+5.82%) | Filing |
| 2022-05-09 2:38 pm Purchase | 2022-05-04 | 13G | CAMP4 Therapeutics Corporation CAMP | HIRSCHMAN ORIN | 95,652 6.100% | 95,652 (New Position) | Filing |